RAG-01 Presentation - Ractigen Therapeutics

Presentations RAG-01 Presentation

First-in-human study of RAG-01, a novel small activating RNA therapeutic in BCG failure Non-Muscle Invasive Bladder Cancer (NMIBC) patients(Abstract)

Event：40th Annual Congress of the European Association of Urology (EAU 2025) (Spain) View Abstract View…

徐春杰March 24, 2025

Presentations RAG-01 Presentation

Development and Clinical Progress of RAG-01, a Novel saRNA Targeting p21 for Non-Muscle Invasive Bladder Cancer Treatment. (Abstract)

Event: 2024 Oligonucleotide Therapeutics Society Meeting (Montreal) View Abstract

ractigenOctober 11, 2024

Presentations RAG-01 Presentation

Preclinical development of RAG1-40-31L: A novel small activating RNA-lipid conjugate targeting tumor suppressor gene p21 for treatment of non-muscle invasive bladder cancer. (Abstract)

Event: 2023 American Society of Clinical Oncology Meeting (Chicago) View Abstract

EnvisionJune 7, 2023

© 2025 Ractigen Therapeutics. All Rights Reserved. Privacy Policy Terms